News & Media

Using qEV columns to determine cargo truly associated with extracellular vesicles and evaluate its biomarker potential in breast cancer: a summary of work by Tkach et al 2022.

The Exoid is yet to reach its second birthday, yet it has already appeared in a number of impressive research articles. Here are our top 3 extracellular vesicle studies featuring the Exoid to date.

Has changing your isolation method changed your EV isolate bioactivity? Or perhaps even their cargo or markers? Here’s why.

The Exoid is a highly accurate, highly tunable device which measures single particles in real time for size, concentration and zeta potential. But don’t just take our word for it. We have the data to back it up.

The qEV2 Gen 2 column is the sixth column to join the Gen 2 range; launched on 17th Jan 2023.

When is an extracellular vesicle an exosome? Turns out, probably less often than you think. Here we delve into EV subtypes and the (lack of) markers to tell them apart.

A summary of work by Chiang et al. 2022, feat. qEV and TRPS for studying OMVs from a nosocomial bacterial pathogen.

Urine is a rich source of EV biomarkers, yet methodology lags behind modern, standardised technology. New studies show size exclusion chromatography as the way forward.

In conversation with Michiel Pegtel, Principal Investigator at Amsterdam UMC and co-founder of Exbiome, about extracellular vesicle isolation, diagnostics, and EV-miRNA biomarker development.

Preeclampsia is a major contributor to premature birth. How might extracellular vesicles play a role in pathogenesis, prediction, and treatment?

World Prematurity Day is recognised on November 17 to raise awareness of the challenges of preterm birth. What role might extracellular vesicles play in this space?

Breaking it down: why choose qEV columns for extracellular vesicle isolation?

Synovial fluid is a highly viscous biofluid containing immune cell-derived extracellular vesicles which could prove key to arthritides, but how should you isolate them? And what is already known about them?

Publications featuring Tunable Resistive Pulse Sensing (TRPS) from Q3, 2022.

Cerebrospinal Fluid presents unique challenges for EV isolation, which has been reflected in a lack of reproducibility in research.

The qEV isolation platform continues to contribute to high quality research, as seen in publications from Q3 2022.

The methods you use for blood collection and processing will impact on the EVs that end up in your isolated sample. Here we discuss the evidence to help you make the right decisions for your research.

Interested in using the qEV10 in your research? Here we highlight some of the best examples of research using qEV10 columns published to date.

Isolation, function, and potential future uses of extracellular vesicles derived from milk – a complex and commonly overlooked biofluid.

The qEV Gen 2 range just got bigger: qEV100 joins the Gen 2 range.

qEV isolation continues to enable diverse studies on extracellular vesicles.

A selection of publications feat. TRPS from Q2, 2022.

Reflecting on the discovery, open questions and potential applications of microRNA, and microRNA derived from extracellular vesicles.

In a systematic study by Gelibter et al (2022), TRPS provides a new insight into the effect of extracellular vesicle storage conditions.

The smallest qEV column has joined the Gen 2 ranks.

The qEV isolation platform continues to play a key role in EV research, as seen in publications from Q1 2022.

5 TRPS publications from Q1 2022

As the Izon team gears up for this year’s ISEV Annual Meeting, we look back on #ISEV2021

Meet qEV10 Gen 2

In line with the ongoing need for a targeted therapy against SARS-CoV-2, Idris et al. (2021) describe the development of a SARS-CoV-2-targeted siRNA-nanoparticle therapy for COVID-19.